title: Blonanserin in the treatment of delirium.
abstract: The purpose of the present study was to provide preliminary data on the usefulness and safety of blonanserin for patients with delirium in the intensive care unit (ICU). The charts of 32 consecutive patients with delirium in the ICU were retrospectively reviewed. These patients were treated with blonanserin. A total of 96.6% had reduction in Memorial Delirium Assessment Scale score. The proportion of patients with side-effects was 24.1%. Blonanserin may be effective and safe in the treatment of delirium in the ICU.
authors.affiliation: Department of Psychiatry and Behavioral Science, Course of Specialized Clinical Science, Tokai University School of Medicine, Kanagawa, Japan. k-kato@tokai-u.jp
authors.forename: Koji
authors.initials: K
authors.lastname: Kato
authors.forename: Keigo
authors.initials: K
authors.lastname: Yamada
authors.forename: Mizuki
authors.initials: M
authors.lastname: Maehara
authors.forename: Fumiaki
authors.initials: F
authors.lastname: Akama
authors.forename: Keitaro
authors.initials: K
authors.lastname: Kimoto
authors.forename: Mai
authors.initials: M
authors.lastname: Saito
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Yano
authors.forename: Atsushi
authors.initials: A
authors.lastname: Ichimura
authors.forename: Hideo
authors.initials: H
authors.lastname: Matsumoto
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D003693:Delirium / Q000188:drug therapy*; D018492:Dopamine Antagonists / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D010880:Piperidines / Q000627:therapeutic use*; D012189:Retrospective Studies; D012702:Serotonin Antagonists / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents; D018492:Dopamine Antagonists; D010879:Piperazines; D010880:Piperidines; D012702:Serotonin Antagonists; C079310:blonanserin